Clinical Trial Update: Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for fecal microbiota transplantation in relapsing Clostridium difficile infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University of Aarhus | Conditions: Clostridium Difficile Infection | Phase 3 | Status: COMPLETED